ASX - By Stock
|
PAA |
Re:
Ann: First Patient of Cohort 2 Dosed in MND Trial
|
|
Banastas
|
79 |
19K |
4 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
79
|
19K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Banastas
|
164 |
40K |
7 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
164
|
40K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Banastas
|
164 |
40K |
12 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
164
|
40K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Banastas
|
164 |
40K |
6 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
164
|
40K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Banastas
|
164 |
40K |
9 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
164
|
40K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Trial Successfully Completes First Patient Cohort
|
|
Banastas
|
164 |
40K |
16 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
164
|
40K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
Banastas
|
97 |
22K |
6 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
97
|
22K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
Banastas
|
97 |
22K |
13 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
97
|
22K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
8 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
1.4K
|
378K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Banastas
|
207 |
48K |
3 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
207
|
48K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Banastas
|
207 |
48K |
0 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
207
|
48K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Banastas
|
207 |
48K |
2 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
207
|
48K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PAA Post AGM ,, 2022 Highlights
|
|
Banastas
|
207 |
48K |
4 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
207
|
48K
|
4
|
|
ASX - By Stock
|
CND |
Re:
Ann: Trading Halt
|
|
Banastas
|
25 |
8.4K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
25
|
8.4K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
Banastas
|
54 |
9.9K |
3 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
54
|
9.9K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
Banastas
|
54 |
9.9K |
4 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
54
|
9.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Webinar
|
|
Banastas
|
42 |
7.9K |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
42
|
7.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
Banastas
|
216 |
48K |
5 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
216
|
48K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
10 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
1.4K
|
378K
|
10
|
|
ASX - By Stock
|
PRM |
Re:
Ann: PRM - Company Update
|
|
Banastas
|
28 |
19K |
1 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
28
|
19K
|
1
|
|
ASX - By Stock
|
PRM |
Re:
Ann: PRM - Company Update
|
|
Banastas
|
28 |
19K |
0 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
28
|
19K
|
0
|
|
ASX - By Stock
|
PRM |
Re:
Ann: PRM - Company Update
|
|
Banastas
|
28 |
19K |
0 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
28
|
19K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
Banastas
|
33 |
7.3K |
0 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
33
|
7.3K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
Banastas
|
33 |
7.3K |
4 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
33
|
7.3K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
1 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
1.4K
|
378K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
7 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
1.4K
|
378K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
6 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
1.4K
|
378K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
7 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
1.4K
|
378K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
3 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
1.4K
|
378K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Latest JP Equity Research Report - July 2022
|
|
Banastas
|
36 |
8.9K |
2 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
36
|
8.9K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
44 |
10K |
11 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
44
|
10K
|
11
|
|
ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
Banastas
|
2.3K |
528K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
2.3K
|
528K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
44 |
10K |
14 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
44
|
10K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
44 |
10K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
44
|
10K
|
3
|
|
ASX - By Stock
|
PRM |
Re:
Potential 150 Bagger
|
|
Banastas
|
225 |
72K |
1 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
225
|
72K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Richard Mollard
|
|
Banastas
|
46 |
11K |
10 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
46
|
11K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Richard Mollard
|
|
Banastas
|
46 |
11K |
7 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
46
|
11K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL tablets arrive in Melbourne for MND Clinical Trial
|
|
Banastas
|
46 |
9.8K |
5 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
46
|
9.8K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
2 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
2 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
4 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
3 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
Banastas
|
65 |
15K |
4 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
65
|
15K
|
4
|
|
ASX - By Stock
|
PRM |
Re:
Ann: New Listed LSE Listed Partner - Sasanof-1 Well
|
|
Banastas
|
11 |
3.3K |
7 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
11
|
3.3K
|
7
|
|
ASX - By Stock
|
PRM |
Re:
Ann: New Listed LSE Listed Partner - Sasanof-1 Well
|
|
Banastas
|
11 |
3.3K |
6 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
11
|
3.3K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Banastas
|
29 |
6.6K |
10 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
29
|
6.6K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Trial Time , MND , SARs / Covid
|
|
Banastas
|
47 |
10K |
5 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
47
|
10K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
Banastas
|
1.4K |
378K |
4 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
1.4K
|
378K
|
4
|
|